|
|
| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Acute Viral Hepatitis Diagnostic with Reflexes (HAV, HBV, HCV)
Test Code10306
CPT Codes
80074
Includes
Hepatitis A IgM Antibody
Hepatitis B Surface Antigen with Reflex to Confirmation
Hepatitis B Core Antibody (IgM)
Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR
If Hepatitis B Surface Antigen is Positive, then confirmatory testing based on the manufacturer's FDA approved recommendations will be performed at an additional charge (CPT code(s): 87341).
If Hepatitis C Antibody is Reactive or Borderline, then Hepatitis C Viral RNA, Quantitative, Real-Time PCR will be performed at an additional charge (CPT code(s): 87522).
Hepatitis B Surface Antigen with Reflex to Confirmation
Hepatitis B Core Antibody (IgM)
Hepatitis C Antibody with Reflex to HCV, RNA, Quantitative, Real-Time PCR
If Hepatitis B Surface Antigen is Positive, then confirmatory testing based on the manufacturer's FDA approved recommendations will be performed at an additional charge (CPT code(s): 87341).
If Hepatitis C Antibody is Reactive or Borderline, then Hepatitis C Viral RNA, Quantitative, Real-Time PCR will be performed at an additional charge (CPT code(s): 87522).
Preferred Specimen
5 mL serum
Minimum Volume
2.5 mL
Other Acceptable Specimens
Plasma collected in: EDTA (lavender-top) tube
Instructions
Dietary supplements containing biotin may interfere in assays and may skew analyte results to be either falsely high or falsely low. For patients receiving the recommended daily doses of biotin, draw samples at least 8 hours following the last biotin supplementation. For patients on mega-doses of biotin supplements, draw samples at least 72 hours following the last biotin supplementation.
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
Room temperature: 72 hours
Refrigerated: 14 days
Frozen: 21 days
Refrigerated: 14 days
Frozen: 21 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic
Methodology
Immunoassay (IA)
Setup Schedule
Set up: Mon-Sat; Report available: 1-3 days
Limitations
Results obtained from immunosuppressed patients should be interpreted with caution. Patients receiving mouse antibody therapy may produce false-negative results. False-positives may be detected shortly after immunization to influenza and with patients with hypergammaglobulinemia, positive rheumatoid factor, and connective tissue disorders.
Reference Range
See individual tests
Clinical Significance
This panel is preferred to evaluate symptomatic patients for viral hepatitis and includes testing for hepatitis A virus (HAV), hepatitis B virus (HBV), and hepatitis C virus (HCV); the 3 most common pathogens of viral hepatitis in the United States [1].
Acute symptoms and signs are similar among HAV, HBV, and HCV infection and may include fever, fatigue, loss of appetite, nausea, abdominal discomfort, dark urine, pale stools, and jaundice [1]. This panel includes 4 tests with reflexes that may help establish diagnosis of these 3 viral hepatitis infections in symptomatic patients: HAV IgM antibody; Hepatitis B Surface Antigen (HBsAg) with reflex confirmation; Hepatitis B Core, IgM; Hepatitis C Virus antibody with reflex to HCV RNA.
If acute HCV infection is suspected, the recommended test is Hepatitis C Antibody with reflex to HCV, RNA, Quantitative, Real-Time PCR. If acute HBV infection is suspected, the recommended test is Hepatitis B Surface Antigen (HBsAg) with Reflex Confirmation. This panel is not intended for asymptomatic screening for viral hepatitis. The results of the test in the panel should be interpreted in the context of pertinent clinical history and examination findings.
References
1. Viral Hepatitis Surveillance - United States, 2019. Centers for Disease Control and Prevention. Accessed January 16, 2021. https://www.cdc.gov/hepatitis/statistics/2019surveillance/pdfs/2019HepSurveillanceRpt.pdf
Acute symptoms and signs are similar among HAV, HBV, and HCV infection and may include fever, fatigue, loss of appetite, nausea, abdominal discomfort, dark urine, pale stools, and jaundice [1]. This panel includes 4 tests with reflexes that may help establish diagnosis of these 3 viral hepatitis infections in symptomatic patients: HAV IgM antibody; Hepatitis B Surface Antigen (HBsAg) with reflex confirmation; Hepatitis B Core, IgM; Hepatitis C Virus antibody with reflex to HCV RNA.
If acute HCV infection is suspected, the recommended test is Hepatitis C Antibody with reflex to HCV, RNA, Quantitative, Real-Time PCR. If acute HBV infection is suspected, the recommended test is Hepatitis B Surface Antigen (HBsAg) with Reflex Confirmation. This panel is not intended for asymptomatic screening for viral hepatitis. The results of the test in the panel should be interpreted in the context of pertinent clinical history and examination findings.
References
1. Viral Hepatitis Surveillance - United States, 2019. Centers for Disease Control and Prevention. Accessed January 16, 2021. https://www.cdc.gov/hepatitis/statistics/2019surveillance/pdfs/2019HepSurveillanceRpt.pdf

